TABLE 2.
Perceived discussion of short‐ and long‐term consequences in SDM process (SDM step 2)
| Discussion of short‐term consequences, % (N) | 80.7 (2626) | |
| Discussion of long‐term consequences, % (N) | 53.1 (1727) | |
| Discussion of short‐term consequences % (N) | Discussion of long‐term consequences % (N) | |
|---|---|---|
| Fatigue | 47.8 (1557) | 25.1 (816) |
| Diminished physical capacity | 38.5 (1254) | 18.7 (610) |
| Sexual dysfunction | NA | 15.8 (515) |
| Nausea/vomiting | 28.9 (940) | NA |
| Gastrointestinal complaints | 24.6 (802) | 10.0 (324) |
| Osteoporosis | NA | 9.0 (293) |
| Hair loss | 24.0 (780) | NA |
| Weight shift/problems eating or drinking | 21.4 (696) | 6.8 (220) |
| Pain | 19.6 (637) | 6.7 (219) |
| Neuropathy | 18.2 (592) | 10.9 (354) |
| Cardiological problems | NA | 5.9 (191) |
| Hormonal dysfunction | 16.2 (527) | 9.0 (293) |
| Oral/dental problems | 15.6 (507) | 4.4 (143) |
| Concentration problems | 13.2 (428) | 8.2 (266) |
| Incontinence | 11.2 (364) | 7.9 (257) |
| Lymphedema | 9.9 (321) | 6.0 (196) |
| Memory problems | 8.8 (286) | 5.9 (191) |
| Depressive symptoms | 8.8 (285) | 5.3 (174) |
| Fertility problems | NA | 4.9 (160) |
| Secondary tumours | NA | 4.0 (130) |
| Dyspnoea/shortness of breath | 6.1 (199) | NA |
| Stress | 5.9 (192) | 3.0 (99) |
| Anxiety | 5.4 (176) | 3.3 (107) |
Note: Higher means or medians indicate more discussion.
Abbreviations: NA, not applicable; SDM, shared decision making.